Development of mitochondrial targeted DDS and nano medicines < MITO-Porter Technology>

• Development of mitochondrial targeted nano medicines
• Validation of mitochondrial gene therapy based on mitochondrial DDS
• Validation of mitochondrial targeted therapy for resistant cancer
• Development of DDS technology to accelerate cell therapy

Research on cell manipulation based on organelle regulation

• Cell manipulation based on organelle regulation
• Development of organelle pharmaceuticals

Control of cancer immune system by nano-DDS

• Development of adjuvant-loaded nano-DDS
• Nano-cancer immunotherapy based on NK cell regulation
• Development of active targeting technology to identify cells at the subset level
• Development of novel cancer therapy based on tumor vascular disrupting

Development of in vivo macromolecular delivery system based on molecular design of novel lipid materials

• Development of functional lipid library
• Regulation of the in vivo fate of LNPs based on nano-bio interactions
• Development of LNPs for genome editing therapy
• Development of vaccine formulations for cancer/infectious diseases